Our network
We collaborate with organisations from across Australia and around the world to raise awareness of pancreatic cancer and accelerate meaningful progress for those affected by the disease.
Australian Pancreatic Cancer Alliance
Who we are
The Jreissati Pancreatic Centre at Epworth is a founding member of the Australian Pancreatic Cancer Alliance - a collaborative network of organisations united by a shared mission to raise awareness of pancreatic cancer and accelerate meaningful progress for those affected by the disease.
Established in 2015 the Alliance recognises the devastating impact and low survival rates associated with pancreatic cancer, and believes that collective action is the most effective driver of change.
What we do
Each member organisation brings unique expertise, resources, and community connections, creating a powerful combined voice for advocacy, education, fundraising, lobbying and support. This unified approach strengthens national awareness campaigns, amplifies key messages, and helps ensure that pancreatic cancer receives the attention it urgently deserves within Australia’s broader health landscape.
The Alliance meets throughout the year, providing a structured and supportive forum for members to share updates, discuss challenges, and identify opportunities for joint initiatives.
By standing together, the Alliance not only strengthens individual organisations but also builds a more cohesive and influential movement dedicated to improving outcomes for everyone impacted by pancreatic cancer in Australia.
Alliance Members
Australian Pancreatic Club
The Australasian Pancreatic Club is an organisation for clinicians and clinical and basic science researchers interested in diseases of the pancreas, with a focus on exocrine function. Its areas of interest increasingly include neuroendocrine disease and diabetes of the exocrine pancreas.
Professor Andrew Metz, Director of the Jreissati Pancreatic Centre at Epworth, is the Treasurer and a member of the Australian Pancreatic Club.
International Association of Pancreatology
The International Association of Pancreatology has over 3500 members comprising of basic scientists and clinical investigators from 32 countries exploring pancreatic biology and pathophysiology in order to find newer treatment and improve outcomes for pancreatic disorders.
Professor Andrew Metz, Director of the Jreissati Pancreatic Centre at Epworth, is a Council member of the International Association of Pancreatology.
Find out more about the International Association of Pancreatology
Pancreatic Cancer Europe
The Jreissati Pancreatic Centre at Epworth is an Associate Member of Pancreatic Cancer Europe, which brings together experts and organisations to improve understanding and awareness of pancreatic cancer, support earlier diagnosis, and advance care and treatment.
Pancreatic cancer is a global challenge, and progress depends on collaboration. Growing our involvement in the global pancreatic cancer community creates new opportunities to work together, share knowledge and help drive progress in research and care.
PRECEDE
The Pancreatic Cancer Early Detection (PRECEDE) study is a global effort to drive early detection of pancreatic cancer, led by a consortium based at UC San Diego. The Jreissati Pancreatic Centre at Epworth contributes our data from the Australian Pancreatic high-Risk ScrEening (APRISE) study to the international collaboration.
APRISE is an Australia-wide research study led by the Jreissati Pancreatic Centre at Epworth, and delivered through a national network of 34 participating hospitals and clinics. It is designed for people whose family history, genetic factors or relevant medical history place them at increased risk of pancreatic cancer.
Eligible participants undertake regular surveillance while contributing data that can help build the evidence for more consistent high-risk pancreatic screening in the future.